Finance

Lists
Why is ZBH up 3,59%?
Dive Deeper
ZBH:NYSE
Zimmer Biomet Holdings, Inc
92,17 $
+3,59%
(+3,19) 1D
92,17 $
0,00% (0,00)
After hours
Closed: 12 հոկ, 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBH...
Open
89,28 $
High
92,23 $
Low
89,18 $
Mkt. cap
17,58 մլրդ
Avg. vol.
2,03 մլն
Volume
0,00
Dividend
1,04%
Quarterly dividend
0,24 $
Ex-dividend date
30 սեպ, 2026 թ.
P/E ratio
22,44
52-wk high
106,88 $
52-wk low
79,12 $
EPS
4,11 $
Beta
0,48
Shares outstanding
190,74 մլն
No. of employees
17 հզր
Open
89,28 $
High
92,23 $
Low
89,18 $
Mkt. cap
17,58 մլրդ
Avg. vol.
2,03 մլն
Volume
0,00
Dividend
1,04%
Quarterly dividend
0,24 $
Ex-dividend date
30 սեպ, 2026 թ.
P/E ratio
22,44
52-wk high
106,88 $
52-wk low
79,12 $
EPS
4,11 $
Beta
0,48
Shares outstanding
190,74 մլն
No. of employees
17 հզր
News stories
From web sources and news partners
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17 հզր
Founded1927
HeadquartersWarsaw, Ինդիանա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 19 analysts giving stock ratings to ZBH in the past 3 months
Buy
Buy
5
Hold
14
Sell
0
12-month forecast
Based on 19 Wall Street analysts offering 12 month price targets for ZBH in the last 3 months.
Highest
Current 92,17 $
120,00 $ (+30,19%)
Average
104,88 $ (+13,79%)
Lowest
93,00 $ (+0,90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mike Kratky
Leerink Partners
Hold
Reiterated
97,00 $
+5,2%
10/12/2026
Gray Powell
BTIG
Hold
Maintained
-
-
10/09/2026
Christopher Pasquale
Barclays
Hold
Initiated
100,00 $
+8,5%
10/07/2026
Matt Miksic
Barclays
Hold
Maintained
100,00 $
+8,5%
10/07/2026
Joanne Wuensch
Citi
Hold
Maintained
99,00 $
+7,4%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
110,00 $
+19,3%
10/01/2026
Travis Steed
Bank of America Securities
Hold
Maintained
110,00 $
+19,3%
09/25/2026
Richard Newitter
Truist Financial
Hold
Reiterated
106,00 $
+15%
09/16/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
117,00 $
+26,9%
08/17/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
100,00 $
+8,5%
08/10/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
104,00 $
+12,8%
08/06/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
98,00 $
+6,3%
08/06/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
08/06/2026
Patrick Wood
UBS
Buy
Maintained
120,00 $
+30,2%
08/06/2026
Lee Hambright
Bernstein
Hold
Maintained
93,00 $
+0,9%
08/06/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
110,00 $
+19,3%
08/06/2026
Vik Chopra
BMO Capital
Hold
Maintained
96,00 $
+4,2%
08/06/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
103,00 $
+11,8%
08/06/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/05/2026
Mathew Blackman
TD Cowen
Buy
Maintained
115,00 $
+24,8%
08/05/2026
Danielle Antalffy
UBS
Buy
Upgraded
115,00 $
+24,8%
07/28/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/23/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
101,00 $
+9,6%
07/13/2026
Unknown Analyst
BMO Capital
Hold
Initiated
95,00 $
+3,1%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
110,00 $
+19,3%
07/06/2026
Caitlin Cronin
Canaccord Genuity
Hold
Reiterated
83,00 $
-9,9%
04/29/2026
David Turkaly
Citizens JMP
Buy
Maintained
105,00 $
+13,9%
04/29/2026
David Roman
Goldman Sachs
Sell
Maintained
88,00 $
-4,5%
02/10/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
2,07 $ / 2,01 $
+2,99%beat
Revenue / Est. (USD)
2,18 մլրդ / 2,14 մլրդ
+1,95%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,00 մլրդ
2,24 մլրդ
2,09 մլրդ
2,18 մլրդ
Cost of goods sold
559,30 մլն
795,50 մլն
594,20 մլն
635,50 մլն
Cost of revenue
559,30 մլն
795,50 մլն
594,20 մլն
635,50 մլն
Research and development expenses
115,90 մլն
118,70 մլն
103,40 մլն
104,80 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
809,40 մլն
838,50 մլն
846,20 մլն
882,30 մլն
Operating expense
1,10 մլրդ
1,13 մլրդ
1,11 մլրդ
1,15 մլրդ
Total operating expenses
1,66 մլրդ
1,93 մլրդ
1,71 մլրդ
1,79 մլրդ
Operating income
340,30 մլն
313,40 մլն
380,80 մլն
391,00 մլն
Other non operating income
6,20 մլն
15,10 մլն
5,50 մլն
6,00 մլն
EBT including unusual items
279,20 մլն
97,90 մլն
301,30 մլն
255,10 մլն
EBT excluding unusual items
269,30 մլն
250,00 մլն
310,20 մլն
320,80 մլն
Income tax expense
48,00 մլն
-39,90 մլն
63,00 մլն
55,50 մլն
Effective tax rate
17,19%
-40,76%
20,91%
21,76%
Other operating expenses
-
-
-
-
Net income
230,90 մլն
139,30 մլն
238,10 մլն
198,30 մլն
Net profit margin
11,54%
6,21%
11,41%
9,11%
Earnings per share
1,90
2,42
2,09
2,07
Interest and investment income
-
-
-
-
Interest expense
-75,40 մլն
-71,90 մլն
-68,80 մլն
-72,90 մլն
Net interest expenses
-75,40 մլն
-71,90 մլն
-68,80 մլն
-72,90 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
623,90 մլն
597,40 մլն
650,80 մլն
661,80 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps